Resmed Inc ADR (RSMDF)

ResMed Inc. DRC is a depositary receipt representing the common stock of ResMed Inc., an issuer in the healthcare equipment and supplies industry listed on OTC Markets. Through its operations, ResMed develops, manufactures, distributes, and markets medical devices and cloud-based software used to diagnose, treat, and manage respiratory disorders in the United States and abroad. Its business is organized into two segments: Sleep and Breathing Health, and Residential Care Software. The company’s product and software portfolio includes sleep diagnostic devices such as ApneaLink Air, NightOwl, and EasyCare Tx, along with connected platforms like AirView and myAir that support remote monitoring and therapy management. ResMed also provides software solutions for home medical equipment, pharmacy, orthotic and prosthetic, home infusion, home health, hospice, skilled nursing, senior living, and residential care providers. Founded in 1989, ResMed is headquartered in San Diego, California.


Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Overall Financial Health Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
OTC-RSMD.F
$23
1.7% Upside
Fair
Not available
Not available
Great
0.0%
October 22, 2026
21.0x
4.9x
5.7x
31.756 B
31.347 B
2.5%
99.4%
12.6
23.0%
108.3%
Valuation • Fair Value

Resmed Inc ADR (OTC-RSMD.F) Fair Value by Valuation Model

Review the available estimates for Resmed Inc ADR (OTC-RSMD.F), including DCF Fair Value, Ben Graham Formula Value, EPV Fair Value, Comps Fair Value.

Primary Valuation Read

Fair Value

$23

Estimated upside of 1.7% versus the current market price.

Fair Value Confidence

Med

Confidence level for the primary fair value estimate.

DCF Fair Value

$24.53

Discounted cash flow valuation reference.

Ben Graham Formula Value

$10.35

Classic Ben Graham valuation formula reference.

EPV Fair Value

$11.58

Earnings power value estimate.

Comps Fair Value

$23.37

Comparable-company valuation reference.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

Use the 6 available valuation references for Resmed Inc ADR (OTC-RSMD.F) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for Resmed Inc ADR (OTC-RSMD.F)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

5.653 B

Current operating scale indicator.

Revenue Forecast

5.803 B

Forward revenue estimate.

EBITDA

2.096 B

Current operating profitability reference.

EBITDA Forecast

2.242 B

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Resmed Inc ADR (OTC-RSMD.F) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Resmed Inc ADR (OTC-RSMD.F)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Great

Positive financial-health read.

Piotroski Score

7

Relatively strong quality score.

Beneish M-Score

-2.63

No elevated caution signal from this screen.

Altman Z-Score

12.6

Relatively strong balance-sheet zone.

FCF / Net Income

108.3%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Resmed Inc ADR (OTC-RSMD.F). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Resmed Inc ADR (OTC-RSMD.F)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Next Earnings Date

October 22, 2026

Days to Earnings

30

Dividend Yield

0.0%

No current dividend yield is indicated.

Payout Ratio

23.0%

Dividend payout reference.

How to read events and dividends

This section helps investors track time-sensitive items for Resmed Inc ADR (OTC-RSMD.F), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Technical Outlook

Technical Signals by Time Frame

Review the technical signals currently available for this stock across supported time frames.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Buy

The 15-minute technical read for Resmed Inc ADR (OTC-RSMD.F) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Buy

The 1-hour technical read for Resmed Inc ADR (OTC-RSMD.F) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Buy

The daily technical read for Resmed Inc ADR (OTC-RSMD.F) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Buy

The weekly technical read for Resmed Inc ADR (OTC-RSMD.F) is currently Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Neutral

The monthly technical read for Resmed Inc ADR (OTC-RSMD.F) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

FAQ Fast Investor Answers

Resmed Inc ADR (OTC-RSMD.F) Stock FAQ

Data-supported answers about Resmed Inc ADR (OTC-RSMD.F), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$23
Estimated upside 1.7%
Valuation Rating
Near Fair Value
Price is close to fair value
Financial Health
Great
Current financial-health read

The current fair value estimate for Resmed Inc ADR (OTC-RSMD.F) is $23. This implies an estimated upside of 1.7% versus the current market price.

Based on the current fair value estimate, the stock is trading close to its estimated fair value.

The current financial health read for Resmed Inc ADR (OTC-RSMD.F) is Great. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Resmed Inc ADR (OTC-RSMD.F) is October 22, 2026.

The latest available data indicates no current dividend yield for Resmed Inc ADR (OTC-RSMD.F).

The current P/E ratio listed for Resmed Inc ADR (OTC-RSMD.F) is 21.0x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Resmed Inc ADR is 31.756 B.

The current enterprise value listed for Resmed Inc ADR is 31.347 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Resmed Inc ADR is OTC-RSMD.F, and the stock is listed on OTC Markets.

Resmed Inc ADR (OTC-RSMD.F) is listed on OTC Markets.

The current debt-to-total-capital ratio listed for Resmed Inc ADR is 2.5%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Resmed Inc ADR is 99.4%. Free float helps investors understand how much of the share base is available for public trading.